Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T14:52:29.350Z.
Calculation as of: 2026-10-06T14:52:29.350Z.
Quote observation: 2026-10-06T14:49:46.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 767633254d5919bd59cda52a5696942c7bb29bc9076435c5b91744fa0c767718
EARNINGS YIELD
N/A
Werewolf Therapeutics, Inc.
Market Cap
$44.80M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$44.84M
Earnings Yield
N/A
TTM Avg
14.15%
3Y Avg
10.66%
5Y Avg
10.66%
Market Cap
$45.32M
Earnings Yield
11.13%
TTM Avg
15.38%
3Y Avg
15.38%
5Y Avg
15.38%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $44.80M | N/A | N/A | N/A | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $44.84M | N/A | 14.15% | 10.66% | 10.66% |
| DarioHealth Corp. (DRIO)vs › | $45.32M | 11.13% | 15.38% | 15.38% | 15.38% |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.69M | N/A | N/A | N/A | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.84M | N/A | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $41.66M | N/A | N/A | N/A | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.81M | N/A | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $48.34M | N/A | 11.78% | 11.68% | 11.68% |
| Clene Inc. (CLNN)vs › | $49.71M | N/A | 8.45% | 8.45% | 8.45% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
